Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
Holland, D P
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis. [electronic resource] - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 06 2016 - 827-31 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article
1815-7920
10.5588/ijtld.15.0006 doi
Antitubercular Agents--therapeutic use
Decision Support Techniques
Ethambutol--therapeutic use
Humans
Isoniazid--therapeutic use
Markov Chains
Pyrazinamide--therapeutic use
Recurrence
Rifampin--analogs & derivatives
Treatment Outcome
Tuberculosis--drug therapy
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis. [electronic resource] - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 06 2016 - 827-31 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article
1815-7920
10.5588/ijtld.15.0006 doi
Antitubercular Agents--therapeutic use
Decision Support Techniques
Ethambutol--therapeutic use
Humans
Isoniazid--therapeutic use
Markov Chains
Pyrazinamide--therapeutic use
Recurrence
Rifampin--analogs & derivatives
Treatment Outcome
Tuberculosis--drug therapy